Rheumatology Billing Built for Biologics and Complex Care

Rheumatology billing is the coding and claims process for practices treating autoimmune and joint conditions, covering infusion administration, J-code biologic drug billing, and prior authorizations for therapies like Remicade and Orencia. It requires precise unit accuracy given the high dollar value of infused biologics.

Outsourcing rheumatology billing gives your practice specialists in infusion coding, biologic authorizations, and drug unit accuracy. Because infusion revenue dominates rheumatology at high dollar values, specialized billing prevents the unit errors and authorization gaps that cost thousands per encounter.

Rheumatology billing services typically charge a percentage of monthly collections, often reflecting the high value of biologic infusions. Because authorization lapses and biosimilar substitution errors are common and costly, specialized billing usually recovers well beyond its cost. Request a free billing analysis to see what your practice could recover.

Yes. Biologics like Remicade and Orencia require prior authorization before the first infusion, along with step therapy documentation showing other treatments were tried first, plus periodic renewals for ongoing therapy. Lapsed authorizations are a leading cause of denied rheumatology infusion claims.

Payers increasingly require specific biosimilars over reference biologic products, and billing the wrong one triggers denials on expensive infusion claims. Tracking each payer's preferred product list and flagging mismatches before administration prevents claims from being submitted for the wrong drug.

Rheumatology claims are most often denied for J-code unit errors, lapsed biologic authorizations, biosimilar policy mismatches, and incorrect infusion hierarchy coding. Because infusion revenue carries such high dollar values, these errors have outsized financial impact compared to visit-based specialties.